产品名称 | NebuSelect™ Recombinant Human IGFBP-3R, hFc-tag |
---|---|
目录号 | NBL-242523 |
别名 | IGFBP-3R; IGFBP-3R; GFBP3R; LOC124446; TMEM219 |
外观 | see COA |
分子量 | Ser39-Arg204 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q86XT9 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242523-100ug | 100ug | Inquire | Inquire | |
NBL-242523-1mg | 1mg | Inquire | Inquire | |
NBL-242523-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IGFBP-3R, hFc-tag
Catalog#:
NBL-242523
Description:
NebuSelect™ Recombinant Human IGFBP-3R, hFc-tag(Cat#NBL-242523) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Ser39-Arg204.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 44.5 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
IGFBP-3R; IGFBP-3R; GFBP3R; LOC124446; TMEM219
Target Information:
Insulin-like growth factor-binding protein-3 (IGFBP-3) is a multifunctional protein known for modulating mitogenic and metabolic actions of IGFs as well as exerting a variety of biological actions not involving IGF. IGFBP-3 inhibits airway inflammation and hyper-responsiveness via an IGF-independent mechanism that involves activation of IGFBP-3R signaling and cross-talk with NF-κB signaling. The IGFBP-3/IGFBP-3R system therefore plays a pivotal role in the pathogenesis of asthma and can serve as a newly identified potential therapeutic target for this debilitating disease.
Amino Acid Sequence:
Ser39-Arg204
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.